Drug executives list pros, cons of health reform

11/18/2009 | Wall Street Journal, The

Health reform legislation could increase drug benefits and decrease the cost of medications, potentially improving the public's perception of the pharmaceutical industry, said Jane Horvath, Merck & Co.'s senior director of public policy. However, the bill could mean more contribution from the industry through "Medicaid-style rebates" and also compromise relationships with academic researchers, said Horvath, whose concerns were echoed by other drug executives at a biotech conference in Philadelphia.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA